Article 51 of the Loi de Financement de la Sécurité Sociale (LFSS 2018) is the most flexible, strategic, and scientifically grounded mechanism France has created to transform care delivery using real-world experimentation rather than theoretical policy reform.
Instead of waiting for national codes to adapt (NGAP, CCAM, GHS, T2A), Article 51 allows local actors to redesign care pathways, deploy new funding models, test digital platforms, and temporarily reimburse activities that are not yet recognised in the national tariff system.
If used correctly, it becomes a fast track for innovation, a policy laboratory, and often the stepping stone to national reimbursement.
What Article 51 Actually Does
Article 51 authorises time-limited pilots (2–5 years) that test new clinical, organisational, or financial models. These pilots operate with:
- Derogatory funding rules
– activities not reimbursed in NGAP or CCAM can be financed
– alternative models (bundled payments, forfaits, capitation, shared savings) - Protected budgets
via the Fonds d’Innovation du Système de Santé (FISS) and regional funds (FIR). - National evaluation
conducted with HTA-aligned methodologies (realist evaluation, RWE, mixed methods).
Article 51 is not a research programme.
It is a system reform tool, designed to test models that could become routine practice.
Who Can Apply

Applications are open to nearly every actor in the ecosystem:
- ARS (regional health authorities)
- Hospital groups (GHT)
- CHU, CH, CLCC
- GP networks & MSPs
- Non-profits and associations
- Start-ups working with health providers
- Federations, CRUQPC, clinical societies
The crucial rule: projects must be submitted with a health provider, not solely by an industrial innovator.
How the Application Process Works
Step 1 — Letter of Intent (Lettre d’intention)
2–4 pages explaining:
- the problem
- the innovation (clinical, organisational, financial)
- expected impact
- target population & region
- why Article 51 is required (derogation, financing needs)
Step 2 — Full Proposal
Co-signed with partners, including:
- clinical pathway redesign
- financial model (forfait, bundled payment, episode-based, capitation…)
- cost impact & projected budget
- KPIs (quality, safety, utilisation, economics, equity)
- governance & technical infrastructure
- RWE and evaluation framework
Step 3 — National Review
Evaluated by:
- Ministry of Health
- CNAM
- Comité Technique de l’Innovation en Santé (CTIS)
Step 4 — Pilot Launch
Funding allocated for 2–5 years.
Derogatory reimbursement begins immediately.
Step 5 — Evaluation
Mid-term + final evaluation using:
- realist methodologies
- RWE-based impact measurement
- mixed quantitative–qualitative evidence
Step 6 — Decision
The Ministry and CNAM choose to:
- generalise the model nationally,
- extend the pilot,
- modify it,
- or terminate.
Generalisation often leads to new CCAM/NGAP codes or new forfaits.
What Article 51 Finances
Unlike traditional act-based reimbursement, Article 51 allows:
✔ Bundled payments
For complete pathways (e.g., bariatric surgery, oncology episodes, dementia).
✔ Flat-rate (forfait) packages
For prevention, follow-up, coordination, case management.
✔ Non-tariffed professionals
psychomotricians, neuropsychologists, occupational therapists, dieticians.
✔ Digital platforms & coordination systems
Including tele-expertise, patient navigation, shared dashboards.
✔ Integrated care models
Health–social care, chronically ill populations, frailty pathways.
Examples of Article 51 Pilots
A. SLDD Occitanie — Universal Access to Neurodevelopmental Diagnostics
- Age 6–15
- Free access to neuropsychology, occupational therapy, psychomotricity
- €21M funded through FISS + FIR
- Evaluation by REES France
- Structured pathway aligned with HAS TSLA guidelines
- Seamless integration with Ma Santé 2022
This project eliminates out-of-pocket costs that previously blocked diagnosis for many families.
B. Obepar — A Bundled Payment for Bariatric Surgery (Île-de-France)
60,000 bariatric surgeries/year in France, but national guidelines for pre-/post-operative care are inconsistently followed.
Key problems:
- poor coordination hospital ↔ community
- non-reimbursed assessments (psychology, dietetics)
- long-term complications
- loss to follow-up
Obepar (four CSOs in Île-de-France) introduces:
- a single forfait covering all pre & post-op steps
- reimbursement of currently non-tariffed professionals
- a coordination hub to reduce loss to follow-up
- recruitment of 2,000 patients over 5 years
- validated by the ARS & Ministry
- designed for national scale-up if efficient
How Organisations Can Use Article 51
If you are a hospital or GHT:
- Redesign a pathway with unmet needs
- Integrate digital tools (navigation, tele-monitoring, triage)
- Build a bundled-payment model
- Add currently non-reimbursed professionals
If you are a start-up:
You cannot lead—but you can:
- partner with providers
- integrate into pathway redesign
- obtain temporary reimbursement for your activity
- generate real-world evidence for HAS/HTA
If you are an ARS:
- Identify regional inequities
- Propose large-scale population pilots
- Coordinate cross-sector integration (health–social care)
Why Article 51 is Becoming a Model for Europe
1. Real-World Evidence Becomes Central
Evaluators use realist science (“what works, for whom, under what conditions”), not RCT-only logic.
2. Financing Follows the Pathway, Not the Procedure
A shift from act-based to value-based reimbursement.
3. National Scalability
Successful pilots become:
- new CCAM/NGAP codes
- new forfaits
- new integrated pathways
4. Equity at the Core
Projects like SLDD Occitanie remove financial barriers entirely.
How to Start a Successful Article 51 Project — A Practical Checklist
Essentials for Success:
- A clearly defined population
- A broken or inefficient current pathway
- Evidence-based redesign (aligned with HAS)
- A strong economic model (cost + avoided costs + outcomes)
- A coordination mechanism (digital or organisational)
- KPIs for clinical, financial, and operational impact
- A credible evaluation partner (REES, research units, universities)
Documents You Will Need:
- Lettre d’intention
- Full project dossier (clinical + financial + pathway + RWE)
- Budget impact analysis
- Evaluation plan
- Partner agreements
- Governance plan
- Deployment roadmap
References
1. Foundational Legal & Policy Documents
- Journal Officiel – Loi de Financement de la Sécurité Sociale 2018, Article 51
- Ministère de la Santé – Article 51: Innovations organisationnelles
- Ministère de la Santé – Guide de financement Article 51 (PDF)
- DREES – Évaluation des expérimentations Article 51
- CNAM/AMELI – Bilan du dispositif Article 51 (Communiqué)
2. Evaluation Science, Realist Methodology & Real-World Evidence
- Launois R. et al. (2021). “Évaluer autrement les parcours Article 51.” Ann Pharm Fr. 80(2):131–144.
- IRDES – Renouveler l’action publique en santé via Article 51 (PDF)
- Haute Autorité de Santé – Guides méthodologiques & parcours de soins
- Pawson R., Tilley N. Realistic Evaluation. Sage Publications, 1997.
3. SLDD / TSLA Occitanie (Neurodevelopmental Pathway)
- Willig T-N et al. (2022). “The Organization of Diagnosis, Care and Funding for SLDD in France.” Frontiers in Pediatrics. 9:652686.
- ARS Occitanie – Parcours TSLA (Site régional)
- REES France – Évaluations TSLA et Article 51
- Ministère de la Santé – Ma Santé 2022
4. Obepar – Bariatric Surgery Bundled Payment Pilot
- ARS Île-de-France – Article 51 et projet Obepar
- Ministère de la Santé – Synthèse des expérimentations Article 51
- SOFFCO – Recommandations nationales chirurgie bariatrique
5. National Overviews & Official Reports
- Ministère de la Santé – Expérimentations Article 51 en cours
- Cour des Comptes – Rapport public annuel (Section innovation en santé)
- Assemblée Nationale – Auditions sur Article 51 (Commission des Affaires Sociales)
6. Additional High-Quality Context Sources
- ARS Hauts-de-France – Article 51: expérimenter et innover
- Alcimed – Insight: Article 51 and care pathway innovation
- Chaire Philosophie de l’Hôpital – Contribution sur l’innovation organisationnelle (PDF)
- OECD – Health system transformation & RWE profiles (France)